Collectively, our study indicated that FoxM1 overexpression enhanced the therapeutic effect of BMSCs on ARDS, possibly through a paracrine mechanism rather than by promoting the differentiation of BMSCs into AT II cells in vivo. The gene discussed is FOXM1; the disease is acute respiratory distress syndrome.